lps from e. coli j5 strain (List Biological Laboratories)
Structured Review

Lps From E. Coli J5 Strain, supplied by List Biological Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lps+from+e%2E+coli+j5+strain/lps+from+e++coli+j5/pmc08294406-108-9-19
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Top down tandem mass spectrometric analysis of a chemically modified rough-type lipopolysaccharide vaccine candidate"
Article Title: Top down tandem mass spectrometric analysis of a chemically modified rough-type lipopolysaccharide vaccine candidate
Journal: Journal of the American Society for Mass Spectrometry
doi: 10.1007/s13361-018-1897-y
Figure Legend Snippet: Agonists were cultured with HEK-Blue hTLR4 cells over a 5-log dose range from 0.1–1000 ng mL−1. W3110 E. coli LPS (red), J5 E. coli LPS (orange), J5 dLPS (pink), J5 dLPS/GBOMP (green), or PHAD (blue) were incubated for 16 hours. Then NF-κB activation was measured by quantification of SEAP in the supernatant. Mean ± SD of duplicate samples and an associated 4-parameter non-linear regression are shown
Techniques Used: Cell Culture, Incubation, Activation Assay
Figure Legend Snippet: Averaged IMS-CID tandem mass spectra of (a) J5 LPS m/z 1071 and (b) J5 dLPS m/z 789 after collision energy ramping. Insets show deprotonated fatty acid product ions’ presence in (a) and absence in (b)
Techniques Used:
Figure Legend Snippet: Zoomed negative mode FT-ICR mass spectrum (R ~ 300,000 FWHM, in absorption mode) after direct infusion of J5 LPS. Eight potential isotopic distribution envelopes can be identified in absorption mode in this 4 m/z window; these are denoted, at the m/z of their respective monoisotopic ions, with blue arrows. (inset) Magnified portion of the spectrum showing fine detail (including the magnitude mode and the proposed overlap between isotopologues from envelopes 2 and 5)
Techniques Used:
Figure Legend Snippet: MS3 CID mass spectra from MS2 product ions representing J5 E. coli lipid A at m/z 1796 (top) and core OS at m/z 1418 (bottom). Similar dissociation phenomena were observed as in MS2 experiments for chemically isolated lipid A and oligosaccharides, indicating feasibility of LPS top down sequencing in this manner
Techniques Used: Isolation, Sequencing
Related Articles
Purification:Article Title: Top down tandem mass spectrometric analysis of a chemically modified rough-type lipopolysaccharide vaccine candidate Article Snippet: Materials Purified (low protein and nucleic acid content) and lyophilized LPS from Article Title: Top down tandem mass spectrometric analysis of a chemically modified rough-type lipopolysaccharide vaccine candidate Article Snippet: Purified (low protein and nucleic acid content) and lyophilized LPS from Cell Culture:Article Title: Top down tandem mass spectrometric analysis of a chemically modified rough-type lipopolysaccharide vaccine candidate Article Snippet: Materials Purified (low protein and nucleic acid content) and lyophilized LPS from Article Title: Top down tandem mass spectrometric analysis of a chemically modified rough-type lipopolysaccharide vaccine candidate Article Snippet: Purified (low protein and nucleic acid content) and lyophilized LPS from Incubation:Article Title: Top down tandem mass spectrometric analysis of a chemically modified rough-type lipopolysaccharide vaccine candidate Article Snippet: Materials Purified (low protein and nucleic acid content) and lyophilized LPS from Article Title: Top down tandem mass spectrometric analysis of a chemically modified rough-type lipopolysaccharide vaccine candidate Article Snippet: Purified (low protein and nucleic acid content) and lyophilized LPS from Activation Assay:Article Title: Top down tandem mass spectrometric analysis of a chemically modified rough-type lipopolysaccharide vaccine candidate Article Snippet: Materials Purified (low protein and nucleic acid content) and lyophilized LPS from Article Title: Top down tandem mass spectrometric analysis of a chemically modified rough-type lipopolysaccharide vaccine candidate Article Snippet: Purified (low protein and nucleic acid content) and lyophilized LPS from Isolation:Article Title: Top down tandem mass spectrometric analysis of a chemically modified rough-type lipopolysaccharide vaccine candidate Article Snippet: Materials Purified (low protein and nucleic acid content) and lyophilized LPS from Article Title: Top down tandem mass spectrometric analysis of a chemically modified rough-type lipopolysaccharide vaccine candidate Article Snippet: Purified (low protein and nucleic acid content) and lyophilized LPS from Sequencing:Article Title: Top down tandem mass spectrometric analysis of a chemically modified rough-type lipopolysaccharide vaccine candidate Article Snippet: Materials Purified (low protein and nucleic acid content) and lyophilized LPS from Article Title: Top down tandem mass spectrometric analysis of a chemically modified rough-type lipopolysaccharide vaccine candidate Article Snippet: Purified (low protein and nucleic acid content) and lyophilized LPS from Gentle:Article Title: Top down tandem mass spectrometric analysis of a chemically modified rough-type lipopolysaccharide vaccine candidate Article Snippet: Materials Purified (low protein and nucleic acid content) and lyophilized LPS from Article Title: Top down tandem mass spectrometric analysis of a chemically modified rough-type lipopolysaccharide vaccine candidate Article Snippet: Purified (low protein and nucleic acid content) and lyophilized LPS from |